Natural Capsules subsidiary allots 1.11 lakh rights shares
Natural Biogenex Private Limited, a material unlisted subsidiary of Natural Capsules, allotted 1,11,202 equity shares of ₹10 each for cash at par on July 10, 2026. The total allotment amount stands at ₹11,12,020, following a previous board approval on May 27, 2026.

*this image is generated using AI for illustrative purposes only.
Natural Biogenex Private Limited, a material unlisted subsidiary of natural capsules , has allotted 1,11,202 equity shares of ₹10 each for cash at par. The allotment aggregates to ₹11,12,020 and was approved by the board of the subsidiary on July 10, 2026. The rights issue was previously approved by the board on May 27, 2026.
Allotment Details
The board of Natural Biogenex Private Limited approved the allotment of the rights issue shares during its meeting held on July 10, 2026. The shares were issued for cash at par, with the total amount aggregating to ₹11,12,020.
| Parameter | Details |
|---|---|
| Entity | Natural Biogenex Private Limited |
| Number of Shares Allotted | 1,11,202 |
| Face Value | ₹10 each |
| Issue Price | Cash at par |
| Total Allotment Amount | ₹11,12,020 |
| Board Approval Date | July 10, 2026 |
| Previous Rights Issue Approval | May 27, 2026 |
The intimation regarding the allotment was submitted to BSE Limited and National Stock Exchange of India Limited under Regulation 30(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Historical Stock Returns for Natural Capsules
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.21% | +1.05% | -4.85% | -13.63% | -32.09% | -42.21% |
How will the infusion of ₹11.12 lakh impact the operational expansion or R&D capabilities of Natural Biogenex?
What strategic initiatives will Natural Capsules Ltd. undertake to leverage this capital injection in its subsidiary?
Will this rights issue lead to any changes in the ownership structure or control of Natural Biogenex?


































